Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12077594 IL2RG binding molecules and methods of use

Patent 12077594 was granted and assigned to Synthekine on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Robert Kastelein0

Sandro Vivona0

Deepti Rokkam0

Patrick J. Lupardus0

Date of Patent

September 3, 2024

0

Patent Application Number

180065250

Date Filed

August 5, 2021

0

Patent Citations

US Patent 8975382 Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors

0

US Patent 8258268 Dual variable domain immunoglobulin and uses thereof

0

US Patent 8921528 Bispecific fusion antibodies with enhanced serum half-life

0

US Patent 10927186 T cell recruiting polypeptides based on TCR alpha/beta reactivity

0

Patent Primary Examiner

Meera Natarajan

0

Patent abstract

The present disclosure relates to biologically active molecules comprising a single domain antibody (sdAb) that specifically binds to the extracellular domain of human IL2Rg, compositions comprising such antibodies, and methods of use thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12077594 IL2RG binding molecules and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool